TScan Therapeutics: Q1 Earnings Insights

TScan Therapeutics TCRX reported its Q1 earnings results on Wednesday, May 10, 2023 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

TScan Therapeutics missed estimated earnings by 25.68%, reporting an EPS of $-0.93 versus an estimate of $-0.74.

Revenue was up $3.78 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.08 which was followed by a 9.04% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for TScan Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.